Spectrum Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 2.12, indicating more challenging environment then in the fourth quarter 2022, but still, it is a far cry from any concerns. Spectrum Pharmaceuticals Inc 's Accounts Receivable average collection period in the Mar 31 2023 quarter, has increased to 172 days, from 139 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector Spectrum Pharmaceuticals Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Spectrum Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SPPI Receivables Turnover Ratio	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter
Y / Y Receivable Change	5164.16 %	1224.22 %	-84.83 %	-82.79 %	-77.65 %
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	2.12	2.62	-	-	-
SPPI's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	172	139	-	-	-
Seq. Receivable Change	147.1 %	2223.04 %	-3.62 %	-4.85 %	-37.84 %
Seq. Revenue Change	54.39 %	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

SPPI Company Profile • Back to SPPI Efficiency Comparisons • Compare SPPI Receivables Turnover Ratio to its Competitors

Financial Statements
Spectrum Pharmaceuticals Inc 's Accounts Receivable	$ 34 Millions	Visit SPPI's Balance sheet
Spectrum Pharmaceuticals Inc 's Sales TTM	$ 26 Millions	Visit SPPI's Income Statement
Sources of SPPI's Revenues		Visit SPPI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SPPI's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SPPI's Growth Rates	SPPI's Roa	SPPI's Inventory Turnover Ratio	SPPI's Dividend Comparisons
SPPI's Profitability Ratios	SPPI's Roi	SPPI's Asset Turnover Ratio	SPPI's Dividend Growth
SPPI's Valuation Ratios	SPPI's Roe	SPPI's Financial Strength Ratios	SPPI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Receivable at quarter ending Mar 31 2023
Acutus Medical Inc	2.09	$ 16.852 Millions	$ 8.059 Millions
Abeona Therapeutics Inc	2.06	$ 1.863 Millions	$ 0.906 Millions
Lexaria Bioscience Corp	2.00	$ 0.347 Millions	$ 0.174 Millions
Guided Therapeutics Inc	1.97	$ 0.035 Millions	$ 0.018 Millions
Co diagnostics Inc	1.82	$ 12.121 Millions	$ 6.650 Millions
Cardiff Lexington Corporation	1.76	$ 11.918 Millions	$ 6.780 Millions
Sab Biotherapeutics Inc	1.76	$ 12.682 Millions	$ 7.219 Millions
Coherus Oncology inc	1.75	$ 183.363 Millions	$ 104.580 Millions
Petros Pharmaceuticals inc	1.73	$ 6.045 Millions	$ 3.498 Millions
Inovio Pharmaceuticals Inc	1.73	$ 16.498 Millions	$ 9.556 Millions
Biocorrx Inc	1.71	$ 0.234 Millions	$ 0.136 Millions
Amarin Corp Plcuk	1.63	$ 295.471 Millions	$ 181.010 Millions
Vyne Therapeutics Inc	1.51	$ 0.398 Millions	$ 0.263 Millions
Precision Biosciences Inc	1.51	$ 30.561 Millions	$ 20.241 Millions
Zevra Therapeutics Inc	1.47	$ 9.372 Millions	$ 6.381 Millions
Novan Inc	1.45	$ 24.920 Millions	$ 17.234 Millions
Venus Concept Inc	1.42	$ 58.410 Millions	$ 41.010 Millions
Intelgenx Technologies Corp	1.41	$ 0.875 Millions	$ 0.619 Millions
Rayont Inc	1.40	$ 4.781 Millions	$ 3.417 Millions
Palatin Technologies Inc	1.31	$ 3.935 Millions	$ 2.996 Millions
Aditxt Inc	1.25	$ 0.942 Millions	$ 0.754 Millions
Orgenesis Inc	1.10	$ 28.955 Millions	$ 26.369 Millions
Bicycle Therapeutics Plc	1.00	$ 15.499 Millions	$ 15.511 Millions
Intelligent Bio Solutions Inc	0.99	$ 1.192 Millions	$ 1.200 Millions
Inmune Bio Inc	0.99	$ 0.249 Millions	$ 0.252 Millions
Cue Biopharma Inc	0.97	$ 0.432 Millions	$ 0.446 Millions
Anavex Life Sciences Corp	0.88	$ 3.886 Millions	$ 4.421 Millions
Insight Molecular Diagnostics Inc	0.87	$ 1.681 Millions	$ 1.926 Millions
Abvc Biopharma Inc	0.83	$ 1.072 Millions	$ 1.293 Millions
Yubo International Biotech Limited	0.66	$ 0.246 Millions	$ 0.370 Millions

Date modified: 2026-08-29T17:28:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.